CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K. Pal, Samer A. Srour, John B.A.G. Haanen et al.|Cancer Discovery|2024Cited by 137
Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid TumorsToshio Shimizu, Anthony W. Tolcher, Amita Patnaik et al.|Clinical Cancer Research|2014Cited by 82